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Quality of Life Considerations on 
Fecal Incontinence
Arantxa Muñoz Duyos and Yolanda Ribas
Abstract
Traditionally, it has been assumed that tests like anorectal manometry and 
endoanal ultrasound are essential in the evaluation of fecal incontinence (FI). 
However, in daily practice, this testing rarely helps in the decision-making, as 
are mainly based on the patient’s symptoms. Moreover, indications and outcome 
evaluation should not be decided by only considering the symptom severity but 
the impact on QoL and patient satisfaction. Nowadays, patients tend to be active 
consumers of health care, so they may participate on the medical decision-making. 
On the other hand, monitoring treatment results are mandatory in current practice. 
Finally, considering the cost of some of the current treatments for FI, changes in 
QoL should be demonstrated before implementing some procedures. For all these 
reasons, the QoL scales should be used, and readers encouraged to become familiar 
with QoL instruments and their limitations. The following chapter will cover almost 
all areas on existing knowledge about QoL in patients with FI: from how many types 
of QOL scales have been described, to the different ways to measure our patients’ 
satisfaction, passing through the difference between severity and QOL, going deep 
on if the improvement of patients treated for FI is reflected enough in the current 
used QOL scales.
Keywords: Quality of Life, Fecal Incontinence, Evaluation, Severity, Patients’ 
satisfaction
1. Introduction
Quality of life (QoL) is the general well-being of an individual including 
all the emotional, social and physical aspects. A half century ago, the WHO 
defined QoL as an “individual’s perception of their position in life in the context 
of the culture and value systems in which they live and in relation to their goals, 
expectations, standards and concerns” [1]. Therefore, the concept was already 
multidimensional including physical, mental and social domains. Health-Related 
Quality of Life (HRQoL) has been defined as the “physical, psychological, and 
social domains of health, seen as distinct areas that are influenced by a person’s 
experiences, beliefs, expectations and perceptions” [2]. In other words, it would 
be an assessment of how the individual’s well-being may be affected over time by 
a disease, disability or disorder.
Patients should be actively involved in the treatment decisions, and therefore, 
the assessment of health perception is essential. Therapeutic outcomes are not 
meaningful if they are not balanced with the patient’s perception of QoL, thus 
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asking patients about their health and QoL before and after a procedure is crucial 
to improve the quality of care. Patient-reported outcomes are reports coming 
directly from patients about how they feel or function in relation to a health 
condition and its treatment without any interpretation by healthcare profession-
als or anyone else [3].
In the last 30 years, different instruments assessing HRQoL and the broader 
concept of patient-reported outcomes have been developed. These instruments 
do not substitute the physical, physiological or biochemical evaluations, as they 
are complementary and represent the patient’s general perception of the effect of 
illness and treatment in different aspects of life such as physical, psychological 
and social [4].
Fecal incontinence (FI) is a social and emotionally devastating condition 
that significantly affects the QoL of patients and their families, and the ultimate 
goal of treatment should be to improve it, being essential to obtain direct data 
from the patient. Considering that it is a symptom, the subjective perception is 
essential in assessing the impact of incontinence on QoL. Patients commonly 
experience embarrassment, and some people limit their social life to assure an 
easy access to a toilet. Unfortunately, given the social stigma associated with the 
condition, many patients do not seek treatment. It has been suggested that the 
prevalence in the general population has been systematically underestimated, to 
the point that it has been proposed that healthcare professionals should improve 
detection by actively enquiring about symptoms of FI in high-risk groups [5]. 
The fact that only 5–27% of people report their symptoms to their physicians 
may justify the low number of published studies assessing the QoL in patients 
with FI [6].
This chapter will cover almost all areas on the existing knowledge about FI 
patients’ QoL.
2. Types of QoL scales
There are two ways of administering questionnaires: by a face-to-face inter-
view or in a self-administered way. Traditionally, face-to face surveys have been 
considered the gold standard because of their ability to obtain high response rates 
and valid data. However, in QoL questions, it seems that less bias in responses is 
produced by self-administered questionnaires due to the embarrassing situation of 
confessing such sensitive questions to an interviewer [7]. Furthermore, face-to-face 
surveys are more expensive.
Having an alternative viewpoint on a patient’s QOL provided by family caregiv-
ers or other proxies is important to avoid excluding patients who cannot respond 
for themselves due to some cognitive impairment, of in case of very young children. 
Furthermore, proxy assessment of health utility may also supplement critical 
information for clinical decision-making on economic evaluations of patients care 
and health of cost-effectiveness and cost-utility analyses [8]. Proxy-patient agree-
ment is lower for more subjective measures (e.g., expectations and satisfaction with 
social activities) compared with more objective ones (e.g., the frequency of social 
participation) [9].
In case of children, parent-proxy rapport can often be a limitation in the 
assessment of QOL [10], with only a few studies evaluating the level of agreement 
between parents and children on a child’s QOL over time. A large study [11] showed 
low to moderate levels of parent-child agreement at baseline and lower agreement 
at follow-up; child’s age and parent’s self-perceived health were the primary factors 
associated with parent-child disagreements over time. Based on these findings, 
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authors recommended direct self-assessment of QOL among children and adoles-
cents as much as possible.
Most QoL questionnaires are self-administered and they take into account both 
the physical and the emotional aspects, which are usually divided in different 
dimensions, the domains.
For the development of a questionnaire, several questions have to be considered:
1. Validity: it is the degree to which evidence and theory support the interpreta-
tions of test scores entailed by the proposed uses of tests [12]. Validity refers 
to whether the questionnaire actually measures what it is intended to measure 
and not something else, so it has to be established whether the questions and 
the responses are phrased appropriately. Thus, it has to be determined how 
representative the questions are (content validity), an association between 
the test scores and the prediction of a theoretical trait has to be demonstrated 
(construct validity), and if the questionnaire is measuring what it is intended 
to measure (criterion validity).
2. Reliability: it is the ability of the questionnaire to yield reproducible and 
consistent estimates of true treatment effect [12]. Reliability means that the 
responses to the questionnaire are reproducible and that it has internal consis-
tency as well.
3. Responsiveness: the instrument should be able to detect the changes in the 
expected outcomes. For instance, if a questionnaire is determining the QoL of 
certain condition, then it should be able to predict the QoL after treating that 
condition.
Furthermore, in order to avoid erroneous research conclusions, the translation of 
questionnaires should undergo an appropriate and rigorous validation process, as it 
was done by the International Quality of Life Assessment (IQOLA) project to trans-
late the S-36 Health Survey [13]. Questionnaires must adapt in a culturally relevant 
and comprehensible form while keeping the original meaning and intention [13, 14].
Studies assessing the QoL in patients with FI have used three types of question-
naires: generic QoL scales, specialized scales and condition-specific scales.
Generic QoL Scales try to cover all aspects of life and are summarized in an 
overall score. They are commonly used to measure QoL in patients with more than 
one disease, and they permit comparison of QoL across groups of patients with 
different medical conditions. Generic scales enable researchers to look at the target 
population relative to other populations. They are usually adequate for detecting 
gross changes in a specific population, but they often lack the specific questions to 
detect subtle changes and, in the case of FI, many remarkable aspects may not be 
reflected. For FI, the most widely used generic questionnaire is the Short Form 36 
Health Status Questionnaire (SF-36) [15].
Specialized scales have been developed for a specific condition or symptom, not 
a specific population. These scales focus on the measurement of a particular aspect 
of QoL, such as the assessment of sleeping disorders in patients with irritable bowel 
syndrome [16] or depression in patients with FI [17]. Specialized scales provide 
two advantages. First, there is a lower probability that other dimensions of life will 
emerge, and the instrument will therefore probably be more responsive to change. 
Second, as with general QoL measures, specialized scales allow for comparison 
across different populations (for instance, comparing the presence of depression 
in FI versus depression in multiple sclerosis). The main disadvantage of specialized 
scales is that the global sense of QoL is not reflected [18].
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Condition-specific scales are specially designed to go deep into QoL aspects 
in each group of patients and its main advantage is that they can be used to detect 
changes in the treated population. However, as expected, these instruments cannot 
be used to compare QoL between different diseases. Four different types of condi-
tion-specific scales have been used to assess QoL in FI, each of them with strengths 
and weaknesses that will be further explained. The first one, the Fecal Incontinence 
Quality of Life Scale (FIQL), has been used as an evaluation tool for patients with 
FI and it has been widely translated [19]. The second one, the Gastrointestinal 
Quality of Life Index (GIQLI) [20], is an instrument for measuring QoL specifi-
cally in patients with gastrointestinal disorders, which has the additional advantage 
of looking at FI relative to other gastrointestinal diseases. Finally, the third type 
would be condition-specific quality instruments, which are designed to assess QoL 
in specific populations. The Manchester Health Questionnaire (MHQ ) [21] was 
adapted to measure the condition-specific QoL related to FI from a validated mea-
sure of urinary incontinence (the King’s Health Questionnaire [22]). Subsequently, 
the Modified Manchester Health Questionnaire (MMHQ ) [23] was developed by 
combining the Fecal Incontinence Severity Scale (FISI) and the MHQ.
3. Measuring the impact of FI: the difference between severity and QoL
Initial scores to assess FI did not include questions about QoL [24, 25]. The most 
frequently used questionnaires, the Cleveland Clinic Continence Score (CCCS) [26] 
and the St Mark’s score [27], have demonstrated and excellent intra and interob-
server reliability [28] and they added a question about lifestyle alterations, with 
answers ranking in time frequency. However, ranking limitations in daily activities 
on the basis of time frequency may be difficult for patients. Furthermore, a person 
who has adapted oneself to deal with episodes of FI over a long period of time may 
not realize the magnitude of the impact that these episodes have been having on the 
activities of daily living.
Moreover, severity scores in FI were developed to be as objective as possible but 
introducing variables such as coping mechanisms and lifestyle changes tends to add 
subjective aspects, thus they should be interpreted with caution [29].
Additionally, some limitations in applying some scores should be mentioned. 
Both the CCCS and the St Mark’s score characterize the frequency of each type of 
incontinence separately (i.e. solid, liquid or gas). However, other authors consider 
that it is difficult for patients to specify and, consequently, their scale has been 
developed using a different grading system, as in the Fecal Incontinence and 
Constipation Assessment (FICA) scale [30].
Moreover, health professionals have an additional difficulty scoring the fre-
quency of liquid stool incontinence. In patients never experiencing liquid stools, 
score could be considered both in the CCCS and the St Mark’s score, but if the ques-
tion is what patient think that it would happen in case that they had liquid stools, 
score could be 4.
Other significant limitations when assessing FI are: (a) most scores do not 
include urgency, with the exception of the FICA and the St Mark’s score and (b) 
the FICA score is the only one that quantifies the amount of leakage, thus in other 
questionnaires the severity of FI would be identical for a minor staining or a large 
bowel leakage once a week [31].
For all the reasons mentioned above, we need to be aware that severity alone 
may not be sufficient to establish a therapeutic decision.
As a result, some authors have tried to correlate the QoL assessments with the 
severity scores. Eypasch et al. [20] determined that patients with a CCCS over 9 had 
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a severe alteration in their QoL measured by the Gastrointestinal Quality of Life 
Índex (GIQLI), and that they rested home with very poor social activities.
Bharucha et al. correlated the FICA symptom severity score and a modification 
of the FIQL scale, and concluded that the FICA score is a simple instrument to use 
in the office, and that it demonstrates reasonably both the physical manifestations 
of FI (i.e. symptom severity) but also the impact on QOL [31].
However, the correlation between severity and QoL questionnaires is still a con-
troversial issue. Impact on QoL varies between patients depending on daily activity, 
work, personality and many other dimensions. While one episode of solid FI might 
represent a significant trauma leading to changes in personal and working life for 
one patient, another one might consider it significant just in the case that it hap-
pened frequently. Consequently, gas incontinence may be a significant problem for 
a young person with an active social and working life, but it may not be considered 
as important for other people.
Rockwood et al. reported that patients acknowledged gas incontinence being 
more severe than what their doctors considered, being the opposite regarding solid 
FI [19]. This difference is due to the fact that severity scores are constructed under 
a pathophysiologic point of view mainly reflecting the doctor’s perspective. Thus, 
gas incontinence is considered less severe by doctors, as they don’t expect to find 
a significant structural or functional disorder when compared with a patient with 
solid stool incontinence.
Furthermore, FI assessment of the outcome of treatments for FI measurement 
should take into account the impact on lifestyle. For instance, improving gas incon-
tinence in a young person with an active working life, could decrease the severity 
score less than 20%, but, however, have a significant impact on QoL.
4. Measuring QoL in fecal incontinence
The Short Form-36 (SF-36) is a multidimensional questionnaire constructed 
to survey health status in the Medical Outcomes Study [15]. It is used in clinical 
practice and research, as well as health policy evaluations and general population 
surveys.
The questionnaire includes 36 items grouped in 8 dimensions: limitations in 
physical activities, limitations in social activities, limitations in usual role activities 
because of physical health problems, bodily pain, general mental health, limita-
tions in usual role activities because of emotional problems, vitality (energy and 
fatigue) and general health perceptions. The SF-36 is scaled from 0 to 100, where 
higher scores represent a better health status. The questionnaire was designed for 
self-administration as well as for administration by a trained interviewer either by 
telephone or in person. The questionnaire has been sufficiently validated and its 
main advantage is that it is easy and relatively fast to fill in, taking 10–20 minutes as 
an average. It is the most used instrument to validate other questionnaires subse-
quently designed and to assess the specific questionnaires.
The SF-36 allows us to compare FI populations with urinary incontinence 
patients or to compare FI populations with altogether different populations, such as 
healthy persons or persons with other chronic diseases [13].
As other generic scales, the main disadvantage of the SF-36 is that while the “role 
physical” measurement might be sufficient to detect changes among persons with 
FI, the “role social” measurement is probably not sensitive enough to detect such 
changes (i.e. going to a movie or travelling) [32].
The Gastrointestinal Quality of Life Index (GIQLI) [15] is a “systemic”, but not 
generic, QoL instrument designed to be administered across all populations with 
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gastrointestinal conditions, which has also been used to assess FI. The questionnaire 
was designed in three phases and it was also validated against other generic mea-
sures of QoL. The GIQLI contains 36 questions, each with 5 response categories, 
in 5 areas: a symptom list, physical issues (function and perception of functional 
ability), psychological issues (primarily affect), social issues and disease-specific 
items (items tied directly to a specific condition, such as bowel urgency for FI). 
The significant advantage of this type of instrument over condition-specific QoL 
measures is its ability to look at FI relative to other gastrointestinal conditions [18].
The FIQL scale is the most widely used condition specific QoL instrument in 
FI. It was developed by a panel of experts, including colorectal surgeons and health 
service researchers, that selected aspects (or domains) of QoL likely to be affected 
by FI [19, 33]. The study included 190 participants (118 patients with FI and 72 
controls) from 5 different clinics. The psychometric evaluation showed that the 
questionnaire produced a reliable and valid measurement of QoL in patients with 
FI. The questionnaire is self-administered, and it includes questions regarding the 
limitations in their activities caused by FI during the last month.
The FIQL scale includes 29 items that are grouped into 4 scales or domains:
• Lifestyle: comprising 10 questions about the limitation in social activities such 
as dining out, travelling, or even basic activities such as shopping.
• Coping/behaviour: including 9 questions relating to the level of concern of FI in 
daily thoughts, and the limitation that represents on sexual relations, work, etc.
• Depression/self-perception: comprising 7 questions about the impact of FI on 
their feelings, and how they see themselves in their environment.
• Embarrassment and feeling of social rejection, including 3 questions.
Possible answers range from 1 to 4, where 1 indicates a low functional status. 
The score of each domain is obtained from the mean of all items. The scale includes 
a “not applicable” category that is coded as a null value in the final sum, although 
the author recommends not to use it as a response option [33]. Thus, the four 
domains are scored from 1 to 4, and the higher score better QoL.
The main advantages of the FIQL scale are that it can be used in all adult popula-
tions with FI regardless their particular characteristics, and that it is sensitive to 
the dynamic relationship between the condition, the treatment, and QoL. A recent 
study re-evaluated the FIQL and confirmed several strengths but also has pointed 
out some limitations warranting a revision [34].
The Manchester Health Questionnaire (MHQ ) [21] was made up of items 
adapted from the King’s Health Questionnaire [22], a condition-specific HRQOL 
to evaluate urinary incontinence. The MHQ contains 31 items that are grouped 
into 9 subscales: general health, physical limitations, social function, role limita-
tions, emotional problems, sexual function, sleep/energy, incontinence impact and 
incontinence severity. Scores range between 0 and 100, a higher score indicating 
impairment of HRQOL. The questionnaire was evaluated for content validity by 15 
females with known FI, and pre-tested for ambiguity and ease of comprehension in 
a group of 15 females without known FI and in 20 midwives. Interestingly, during 
pre-testing, it was found that women had difficulty understanding words such as 
“fecal” and “stool” and thus, wording was replaced with the term “bowel leakage.” 
The final questionnaire showed excellent internal consistency, test-retest reliability, 
criterion validity and construct validity.
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Scores on the MHQ were compared with scores on the SF-36 reaching modest 
to strong correlations depending on the domain, but the pattern of correlation 
between the individual scales of the measures was not specified.
As the instrument appeared promising, it has been suggested that further 
research is required to validate the measure and test sensitivity to change, before it 
could be used as a primary end point for studies. Moreover, research comparing the 
MHQ and the FIQL scale would be also useful as the sampled content is similar [32].
The Modified Manchester Health Questionnaire (MMHQ ) [23] is a telephone-
administered version of the Fecal Incontinence Severity Scale (FISI) [29] and the 
Manchester Health Questionnaire [21]. Questions from the FISI were combined 
with similar questions from the MHQ , and some of the MHQ questions, which 
had been validated in the UK, were rephrased to make them more consistent with 
American English. Although the authors planned to collect data from 50 female 
patients, they achieved a relatively small sample as only 30 patients provided data, 
being incomplete in 4 of them. The MMHQ includes 8 subscales: overall impact, 
role limitations, physical/social limitations, personal relationships, emotions, sleep/
energy, sexual activity and lifestyle adaptation. The MMHQ is scaled from 0 to 100, 
for total and subscale scores, where higher scores represent a negative impact on 
HRQOL. In an invited commentary in the same article, Rockwood considered that 
whether the MMHQ is a viable instrument for a telephone assessment of QoL in FI 
remains to be established due to the risk of measurement error [23].
The International Consultation on Incontinence Questionnaire–Bowel 
Symptoms (ICIQ-B) [35] was developed by a multidisciplinary team of clinical 
experts in order to evaluate symptoms of FI and impact on HRQOL in a general 
adult population. The goal was to design an instrument including the patient’s input 
that could be used globally in clinical practice or research. The ICIQ-B has 21 items 
evaluating bowel pattern, bowel control and HRQOL. Scores are generated for each 
section; the higher the score, the greater the symptom severity and bother to the 
patient. The instrument has undergone psychometric evaluation and deemed to be 
valid, reliable and responsive, and it is well suited to clinical practice. The question-
naire also queries the patient to rank issues that are most bothersome.
There are other types of impact measures less frequently used that need to be 
mentioned. Although further investigation is required, they might prove to be use-
ful tools in the future.
The TyPE specification designed by Wexner and colleagues [36] was developed 
to measure the fear of incontinence and how activities were affected by using a 
single question: “During the past 4 weeks, did fear of bowel accidents or leakage 
limit your participation in the following activities?”. Listed activities are: walking, 
vigorous exercise, household chores, visiting friends, driving, sexual relations, 
employment, traveling, church or temple attendance and shopping. There are no 
summary scores for the measure, and thus, each item is evaluated individually. Very 
little information is available about the development of the measure and informa-
tion on reliability is not available.
The Direct Questionning of Objectives (DQO) measure consists of a highly 
personal assessment, constructed on the basis of each patient’s feelings. To calculate 
the DQO, patients list different objectives that are important for them, such as 
travelling or working, rate the importance of each objective on a scale and also rate 
their ability to perform that objective in another scale, both from 0 to 10. The prod-
uct of ability and performance for each objective is calculated and divided by 10. 
This number is added for all objectives and divided by the importance scores for all 
objectives, resulting in a score from 0 to 1.0. The main disadvantages of this system 
of ranking the impact are: (a) the initial generation of objectives and importance 
Current Topics in Faecal Incontinence
8
ratings require assistance by trained personnel; (b) it is a cognitively more complex 
task than completing a questionnaire and (c) measuring only certain individualized 
objectives may decrease the validity of the measure when groups of patients are to 
be compared. However, on the other side, the result is directly relevant to a specific 
person, so it would be more useful when deciding the treatment of an individual 
patient. This measure has been used to assess the QoL in patients on home paren-
teral nutrition after surgery for inflammatory bowel disease and also to assess the 
impact of neuropathic FI on QoL [37].
A study [38] analyzing the validation of QoL measures in FI concluded that the 
scales with the strongest degree of validity are the GIQLI, FIQL and the ICIQ-B 
although all of them have some deficiency. The FIQL is the most widely used by 
far, the main reason for this probably being that it was constructed on a strong 
methodological basis, being useful and sensitive to change. However, there may be 
other factors such as habit and the easiness to use it, as it has fewer domains than 
other questionnaires. Furthermore, the FIQL scale has been translated into many 
languages (French, Portuguese, Italian, Spanish, Turkish, German, Norwegian and 
Japanese).
5. What do we know about QoL in patients with FI?
Over the last 25 years, there have been improvements in the understanding, 
diagnosis and treatment of FI. Although FI has a major impact on QoL, it was not 
discussed in the literature until 15 years ago.
Few studies in elderly patients showed alterations in specific domains of the 
SF-36 questionnaire, such as the emotional role, mental health and physical role 
[39, 40]. However, in younger populations, the assessment of the impact of FI 
on QoL including specific questions such as change in eating patterns, work, 
social and sexual activities, only began when disease-specific measures were 
designed (Table 1).
Initially, aspects concerning QoL came from epidemiological studies performed 
in the general population. Perry and colleagues [41] designed a population-based 
study using a postal questionnaire that was mailed to almost 16,000 subjects aged 
40 years or more. Although it was published in 2002, the study was designed before 
the development of the FIQL scale, and QoL was measured using general questions: 
Do your bowel symptoms: bother you?; cause you any physical discomfort?; inter-
fere with your daily activities?, interfere with your social life?; affect your relation-
ships with other people?, upset or distress you?, affect your sleep? and affect your 
overall QoL? Overall, the prevalence of at least a monthly leakage was 3.3% and the 
prevalence of soiling was 2.7%. Half of the patients with major FI and, interestingly, 
16% of patients with minor FI reported that their bowel symptoms had a significant 
impact on their life. Nearly two thirds of this group reported to need help for their 
symptoms.
A panel of experts including colorectal surgeons and health service research-
ers, was invited to identify QOL-related domains adversely affected by FI, 
leading to the development of the FIQL scale [19]. An extensive research in two 
distinct populations demonstrated that patients with FI had a significantly lower 
QoL than the control population (patients with other gastrointestinal problems). 
The study demonstrated that these patients reduce activities that other people 
take for granted such as shopping, going to the cinema, dining out or having 
sexual intercourse. They suffer from embarrassment, shame and sometimes 
depression. This was the first evidence that specific daily activities are affected in 
patients with FI.
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Author Year N Population 
studied
Questionnaires QoL alterations
O’Keefe et al. 
[39], Edwards 
and Jones [40]
1995
2001
704
2818
Elderly patients SF-36 -Emotional role, 
mental health, and 
physical role
Perry et al. [41] 2002 16.000 Population-
based study, 
>40 years old
Postal 
questionnaire
Specific 
questions
“Do your bowel 
symptoms:….?”
−50% with major FI 
and 16% with minor 
FI reported that 
bowel symptoms 
had a negative 
impact on their life
-Nearly two thirds of 
this group said they 
wanted help with 
symptoms
Rockwood et al. 
[29]
2000 190 FI vs. other 
gastrointestinal 
disorders
FIQL -FI patients reduced 
shopping, going to 
the cinema, dining 
out or having sexual 
intercourse
-FI patients 
suffer from 
embarrassment, 
shame and 
sometimes 
depression
Bordeianou et 
al. [42]
2008 502 Patients 
referred to a 
Pelvic Floor 
Centre because 
of FI
FIQL
+
SF-36
-All domains of 
FIQL significantly 
altered
-Coping-behaviour 
and embarrassment 
the two most 
affected
-SF-36 scores 
decreased as the 
severity of FI 
increased, with 
the exception of 
the scales on pain, 
physical role and 
physical functioning
-FI patients were 
worse than those 
with rheumatoid 
arthritis or diabetes, 
and as severely 
affected as patients 
with inflammatory 
bowel disease
Bharucha et al. 
[30]
2006 2800 Population-
based study
Postal 
questionnaire
FIQL 
adaptation
FICA score
-Urgency affect 
more QoL
-<1 episode/month 
had important 
impact on QoL
-More affected 
activities in which 
toilet access was 
unpredictable 
or activities that 
involved eating
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Some years after the development of the FIQL scale, Bordeianou and Rockwood 
published a prospective analysis of the correlation between severity and QoL, 
using two tools designed for the same group, the FISI for severity and the FIQL 
scale, and also the SF-36 [42]. All the domains of the FIQL were significantly 
altered, being coping-behaviour and embarrassment the two most affected sub-
scales. Furthermore, SF-36 scores decreased as the severity of FI increased, with 
the exception of the scales on pain, physical role and physical functioning, which 
was expectable as usually alterations in the QoL of patients with FI are social and 
emotional. Moreover, the authors reviewed the SF-36 alterations in other chronic 
diseases managed in an outpatient setting and reported that patients with FI were 
worse than those with rheumatoid arthritis or diabetes, and as severely affected as 
patients with inflammatory bowel disease.
Author Year N Population 
studied
Questionnaires QoL alterations
Boreham et al. 
[43]
2005 457 Women 
presenting for 
gynecologic 
care
FIQL
FISI
-Embarrassment 
the most affected 
domain
-Almost 50% 
thought that there 
was no treatment 
available
-Few of them had 
previously sought 
care
Bartlett et al. 
[44]
2009 154 Patients 
attending a 
urogynecology 
and colorrectal 
clinic for other 
conditions
FIQL -QoL severely 
affected by FI in all 
four scales
-Increased bowel 
frequency, quantity 
of fecal loss, type of 
incontinence and 
fecal urgency
-No difference 
in QOL when 
comparing weekly 
and monthly 
incontinent episodes
Markland et al. 
[45]
2010 155 Women 
presenting 
with FI in a 
specialty clinic
MMHQ
FISI
-Younger women had 
worst QoL
-Increased bowel 
movement 
frequency and 
urgency worst QoL
-Urinary 
incontinence, prior 
cholecystectomy and 
prior hysterectomy 
worst QoL
-Loose or watery 
stool was not a 
factor for increased 
MMHQ scores
Table 1. 
What do we know about QoL in patients with FI?
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Since the publication of the FIQL scale, most studies have used this tool to 
measure the QoL in FI. Bharucha et al. [31] mailed a questionnaire to an age-strat-
ified random sample of 5300 women treated at two primary care centres covering 
80% of a population of 100.000 inhabitants. Subjects with FI during the previous 
year were assessed by a symptom severity validated scale (Fecal Incontinence and 
Constipation Assessment, FICA) [30] and a QoL scale consisting in 15 domains 
adapted from the FIQL scale. The survey was answered by 2800 women and the 
prevalence of FI was 18.5%. FI had a moderate or severe impact on one or more of 
the 15 QoL domains in 23% of the women with FI. The study demonstrated that 
urgency affects more QoL than passive FI alone, being worse if both types of FI 
are associated, probably due to the anxiety generated by the urgency. Interestingly, 
women with less than one episode of leakage per month had more impact on their 
QoL than those patients with the lowest QoL. Furthermore, they found that scores 
for activities in which toilet access was unpredictable (i.e. going to the cinema, 
shopping, recreational activities or sports, leaving home, travelling by car, plane or 
train) and for activities that involved eating (i.e. eating before leaving home, going 
out to eat) were higher (indicating worse QoL) than scores for activities associated 
with predictable toilet access (i.e. employment, working home, sex life, visiting 
friends or relatives, staying overnight away from home and family relationships).
Boreham [43] studied FI in 457 women presenting for gynaecologic care on 
benign conditions, and reported that prevalence of FI was 28.4%. Moreover, even 
when the authors considered FI that had an impact on the QoL (answering anything 
except “never” on the FIQL scale), the prevalence of FI reached 21.7%. Of the 130 
women with FI, 76.2% scored very low in the FIQL scales, being also embarrass-
ment the most affected domain. Women with liquid stool leakages reported the 
largest impact on QoL. Another important aspect that impacts the QoL of patients 
with FI is the feeling that they are compelled to adapt to their poor situation for 
the rest of their lives. This study showed several interesting facts: (a) almost three 
quarters of women reported that FI symptoms were present for 3 years or less; (b) 
only 11.4% of them had previously sought care; (c) predictors of health care seek-
ing included loss of solid stool and lower scores on the FIQL embarrassment scale 
and (d) 44.7% of women thought that there was no treatment available.
The findings of this study explain why this condition has been referred to as 
“the silent affliction” or “the unvoiced symptom” [46, 47] because of the associ-
ated stigma. Moreover, we must consider that the overall prevalence of FI is also 
underestimated because health professionals do not ask about this problem. Aitola 
et al. reported that only 27% of patients had discussed FI with their physician [48]. 
Dunivan et al. found that 36% of primary care patients reported FI but only 2.7% 
carried FI as a medical diagnosis, thus suggesting a lack of knowledge by health 
professionals [49].
Bartlett and colleagues [50] studied the major reasons for non-disclosure of FI 
symptoms in patients attending a urogynaecology and colorectal clinic for other 
conditions. They identified that main reasons were: FI historical but not current; 
problem not considered as FI by the patient; administrated questionnaires too long; 
embarrassing condition; doctor considered too busy; patient wanted to focus on 
the primary reason for consultation and the doctor explained that a one-off bout 
of uncontrollable diarrhoea was not FI. Nevertheless, interviewees reported that 
patients would respond to FI questions initiated by their general practitioner during 
regular consultations.
Later on, the same group [44] reported that more than 22% of patients that 
attended urogynaecology and colorectal clinic for other conditions than FI, had 
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a QoL severely affected by FI in all four scales. Factors affecting the QoL were 
increased bowel frequency, quantity of fecal loss, type of incontinence and fecal 
urgency. Patients with both solid and liquid incontinence reported a poorer QoL 
than those with either only solid or liquid incontinent episodes. Given the relation-
ship between the FIQL scales and the quantity of fecal leakage, the authors sug-
gested that the quantity of fecal loss as well as frequency, type, urgency and pad 
wearing should be included in the definition of FI severity [44]. Another interesting 
aspect of this study was the small difference found in the FIQL scales when compar-
ing weekly and monthly incontinence episodes, as other authors have previously 
reported [29], probably because infrequent incontinence episode are always 
unexpected, and hence, similarly distressing.
Several studies have assessed a potential difference between genders concerning 
the impact on QoL, with women experiencing a greater impact when compared 
with men [51, 52]. However, this has not been supported by other reports which 
failed to find significant differences [44, 53].
Studies using other scales such as MMHQ have been also reached interesting 
conclusions. Markland [45] studied women presenting with FI and reported a 
weak correlation between the FISI severity score and the MMHQ. Younger women 
(<65 years) had higher MMHQ scores, representing a negative impact on HRQoL 
and the authors suggested that young patients were more likely to report their 
limitations and seek treatment. However, other studies found that older women had 
worse QoL than younger women, and justified that a delay in treatment resulted in 
poorer QoL [50]. Thus, further studies are needed to address the impact on QOL 
depending on the age. In the same study [45], increased bowel movements and 
urgency were associated with significantly higher MMHQ scores. After controlling 
for age and comorbid disease, women reporting more bowel urgency had increased 
MMHQ score. Urinary incontinence, prior cholecystectomy and prior hysterectomy 
were also associated with increased QoL scores. Interestingly, loose stool or diarrhea 
was not a significant factor for increased MMHQ scores in the multivariate analysis.
A prospective study including women with FI investigated the relationship with 
depression and abdominal pain [54]. Depression was assessed by the Patient Health 
Questionnaire (PHQ ) [55]. Diabetes, prior hysterectomy, abdominal pain, history 
of previous health care for FI and higher FISI scores were associated with more 
severe QoL scores. Furthermore, higher PHQ scores predicted worse QoL scores 
overall and in all four of the FIQL subscales. Other studies have reported a relation 
between FI and depression [56]. This is an important fact to take into account, 
because patients with FI are required to cooperate in the management plan, and 
those suffering from major depression will be less likely to follow a rigorous pro-
gram. Obviously, FI itself may be the main factor for a depression status; therefore, 
being aware of it and helping patients is likely to improve the overall treatment.
A study [57] with a cross-sectional design including 2269 ethnically diverse 
women aged 40–80 years, investigated the impact of FI on sexual QoL. The 
majority (60%) was sexually active despite having FI, but their sexual function 
was impaired. The multivariate analysis showed that women with FI experienced 
significantly lower sexual desire, lower sexual satisfaction, and limitation of 
sexual activity. Women with isolated gas incontinence reported sexual function-
ing similar to women without FI. The authors concluded that sexual life should be 
evaluated and prioritized during therapeutic management, as it is important to 
women with FI.
In conclusion, key points could be summarized as follows:
1. FI is a frequent condition with a higher prevalence of that reported in previous 
studies.
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2. FI has been a neglected problem worldwide. Reasons for non-disclosure and 
non-detected FI are multifactorial and related to the fear of embarrassment, 
but also to the lack of professionals dealing with the problem.
3. QoL of patients with FI is severely affected in almost all life domains.
4. The FIQL scale seems to be a useful and essential tool to assess QoL. Altera-
tions in almost all domains have been demonstrated, especially in coping and 
embarrassment scales.
5. The relationship between severity and QoL in FI is a complex matter, but it has 
been suggested that the quantity of loss, bowel urgency and increased bowel 
frequency should be measured and taken into account.
6. More specific aspects, such as depression or sexual activity, should also be 
introduced in the evaluation of these patients in order to improve the quality of 
health care.
6.  Is the improvement of patients treated for FI reflected enough  
in the QOL scales?
For the last 10 years, most studies regarding FI treatments have analyzed its 
impact on QOL. The FIQL scale has been the most used score to evidence such 
improvement, thus responsiveness of this score has been widely demonstrated.
A systematic review [58] about outcomes after anal sphincter repair showed 
that, although continence deteriorates in the long-term, QoL and satisfaction 
remained relatively high. The scales used in the studies were heterogeneous and, 
despite most studies were published after the development of the specific QoL 
scores, less than half used them.
Since the first multicentre European study about the feasibility of sacral neuro-
modulation [59], most centres regularly use the FIQL scale and some of them also 
add the SF-36. Consequently, most articles on this treatment mention the improve-
ment in the four domains of the FIQL scale correlating with the FI improvement, as 
well as some changes in the generic questionnaire. However, few studies go deeper 
into the details of the meaning of these changes.
A report about the long-term outcome and QoL in patients treated by sacral neuro-
modulation showed a significant and stable improvement in all four categories of the 
FIQL scale, in contrast to the SF-36 score, which only showed a significant improvement 
in the social functioning, emotional and mental health subscales, probably due to its 
generic profile [60]. On the other hand, other studies have demonstrated the quick onset 
on this QoL improvement, which is already present at 3 months follow-up [61–63].
The Sacral Nerve Stimulation Study Group in the USA [64] reported in-depth 
details about changes in QoL from baseline through 4 years of follow-up. They 
reported that not only the four FIQL scales were significantly improved but there 
was also an improvement in each of the component questions. Before the treatment, 
patients tended to stay close to a toilet, thought about the impact of food on their 
bowel function, disliked their body image, and were very limited in their personal 
intimate life. After sacral neuromodulation, less patients were worried about the 
proximity to a toilet, were fearful to sleep elsewhere than at home, avoided travel-
ling by plane or train, disliked their body image. Patients also reported an improve-
ment in their sexual life. Moreover, patient-reported overall health was significantly 
improved, demonstrating a general perception of improvement in wellbeing 
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beyond the mere restoration of continence. Furthermore, they demonstrated that 
Embarrassment and Copying-Behaviour were the most affected dimensions, and 
that correlated better with clinical improvement than Depression and Lifestyle sub-
scales. This fact could be explained because even if patients are not fully continent, 
their QoL is better secondary to less episodes of FI, but they still remain affected by 
all the changes that altered their lives during the time that they suffered FI.
Other reports have highlighted the impact of different surgical treatments, such 
as injectable bulking agents, artificial bowel sphincter or dynamic graciloplasty, on 
the QOL of patients with FI [44].
7. Measuring patient satisfaction
The current role of clinicians has changed from helping patients through their 
illness, to have higher expectations that include both cure and alleviate chronic 
symptoms. Moreover, patients tend to be active consumers of health care, so they 
may participate on the medical decision-making. On the other hand, monitoring 
treatment results is mandatory in current practice. For all these reasons, the QoL 
scales should be used, at least when treatment outcomes are measured.
Nevertheless, the question is whether they are practical and whether its use in 
the clinical practice is realistic. On certain occasions, decisions based on clinical 
improvement and patient satisfaction need to be made, and sometimes is impossible 
to score a QOL scale, in the outpatients’ clinic context.
Some studies have reported simple ways to measure patient satisfaction, which 
are complementary to the application of QOL scores. This implies the addition of 
study-specific customized questions, typically focusing on subjective measures of 
satisfaction or QOL (i.e. “Would you recommend a sphincteroplasty to a friend?” 
or “Are you pleased with the results of your surgery?”). Other authors have used a 
Likert Scale or Visual Analogue Scales (VAS) to measure patient’s satisfaction with 
the outcome [58].
A study [28] measuring the efficacy of different tools used in FI patient’s 
evaluation, demonstrated and excellent intra and interobserver reliability of both 
CCCS and St Mark’s score. Moreover, all domains of the FIQL demonstrate excellent 
intraobserver reliability, although a simple quality of life assessment tool such as 
VAS still maintains a better intraobserver agreement.
The relationship between patient’s satisfaction and clinical outcome, assessed by 
bowel diaries and symptom scores, was evaluated in a study on sacral neuromodula-
tion [65]. Patients were asked to indicate if they were satisfied with their current 
treatment results, with a simple question (yes/no) that simplified the analysis of 
predictive factors of outcome. It was evident that this relationship is complex and 
does not match the traditional used success criteria.
In another study [64], patients were asked to rate his/her own bowel health on a 
scale from 0 to 10, 0 indicating the worst imaginable situation and a 10 indicating 
the best one.
There is no consensus on what is the best way to measure patient satisfaction 
easily, but it is clear that the way to evaluate patients must improve and its valida-
tion must be a future line of research.
8. Final comments
Traditionally, it has been assumed that testing is essential in the evaluation 
of FI. Anorectal manometry and anal ultrasound have been considered the most 
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useful and available tests to assess FI. Investigations would be clearly useful for 
patients with a sphincter injury that could benefit from surgical repair. However, 
in daily practice, the reality for the majority of patients is that testing rarely helps 
in the decision-making, as decisions are mainly based on the patient’s symptoms. 
It is commonly known that some patients with mild clinical symptoms may have a 
severe dysfunction when tested, and on the contrary, there are patients experienc-
ing severe FI but showing minor structural and functional alterations. Moreover, 
treatment decisions and outcome evaluation after treatment should not be decided 
only considering the symptom severity but the impact on QOL and the patient 
satisfaction. Finally, considering the economic cost of some of the current treat-
ments for FI, changes in QoL should be demonstrated before implementing certain 
procedures.
Society is evolving, which implies changes in lifestyle and the possibility of 
new treatments in the future. Therefore, it might be necessary to rethink the way 
of assessing QoL, and that questionnaires will need to evolve as well, to adapt to 
the new circumstances. Readers must be encouraged to become familiar with QoL 
instruments and their limitations.
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Nomenclature
FI fecal incontinence
QoL quality of life
HRQoL health-related quality of life
IQOLA international quality of life assessment
SF-36 short form 36 health status questionnaire
FIQL fecal incontinence quality of life scale
GIQLI gastrointestinal quality of life index
MHQ Manchester health questionnaire
MMHQ modified Manchester health questionnaire
FISI fecal incontinence severity scale
CCCS Cleveland Clinic continence score
FICA fecal incontinence and constipation assessment
ICIQ-B international consultation on incontinence questionnaire–bowel 
symptoms
DQO direct questionning of objectives
PHQ patient health questionnaire
VAS visual analogue scales
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